参考文献/References:
[1] Bousson V, Moretti JL, Weinmann P, et al. Assessment of malignancy in pulmonary lesions:FDG dual-head coincidence gamma camera imaging in association with serum tumor marker measurement[J]. J Nucl Med, 2000, 41:1801-1807.
[2] Ak I, Blokland JAK, Pauwels EKJ, et al. The clinical value of 18FDG detection with a dual-head coincidence camera:a review[J]. Eur J Nucl Med, 2001, 28:763-772.
[3] Delbeke D, Sandler MPl. The role of hybrid cameras in oncology[J]. Semin Nucl Med, 2000, 30:268-280.
[4] Patton JA, Turkington TG. Coincidence imaging with a dual-head scintillation camera[J]. J Nucl Med, 1999, 40:432-441.
[5] Ruhlmann J, Oehr P, Biersack HJ, et al. PET in oncology[M]. Berlin:spriger, 1999. 10-14.
[6] Lowe VJ, fletcher JW, Gobar L, et al. Prospective investigation of positron emission tomography in lung nodules[J]. J Clin Oncol, 1998, 16:1075-1084.
[7] Bar-Shalom R, Valdivia AY, Blaufox MD, et al. PET imaging in oncology[J]. Semin Nucl Med, 2000, 30:150-185.
[8] Bury T, Dowlati A, Paulus P, et al. Whole-body 18F-FDG positron emission tomography in the staging of non-small cell lung cancer[J]. Eur Respir J, 1997, 10:2529-2534.
[9] Drane WE, Abbott FD, Nicole MW, et al. Technology for FDG-SPECT with a relatively inexpensive gamma-camera[J]. Radiology, 1994, 191:461-465.
[10] Martin WH, Delbeke D, Patton JA, et al. Detection of malignancies with SPECT versus PET, with 18F-fluorodeoxyglucose[J]. Radiology, 1996, 198:225-231.
[11] Shreve PD, Steventon PS, Deters EC, et al. Ocologic diagnosis with 18F-fluorodeoxyglucose imaging:dual-head coincidence gamma camera versus positron emission tomogaphic scanner[J]. Radiology, 1998, 207:431-437.
[12] Tatsumi M, Yutani K, Watanabe Y, et al. Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer:comparison with FDG PET[J]. J Nucl Med, 1999, 40:566-573.
[13] Delbeke D, Patton JA, Martin WH, et al. FDG PET and dual-head gamma camera positron coincidence detection imaging of suspected malignancies and brain disorders[J]. J Nucl Med, 1999, 40:110-117.
[14] Weber W, Young C,. Abdel-Dayem HM, et al. Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma camera[J]. J Nucl Med, 1999, 40:574-578.
[15] Higashi K, Ueda Y, Seki H, et al. Fluorine-18-FDG imaging is negative in bronchioloalveolar carcinoma[J]. J Nucl Med, 1998, 39:1016-1020.
[16] Kapucu LO, Meltzer CC, Townsend DW, et al. Fluorine-18-fluorodeoxyglucose uptake in pneumonia[J]. J Nucl Med, 1998, 39:1267-1269.
[17] Israel O, Keidar Z, Iosilevsky G, et al. The fusion of anatomic and physiologic imaging in the management of patients with cancer[J]. Semin Nucl Med, 2001, 31:191-205.
相似文献/References:
[1]川玲.双探头符合线路技术和检测肿瘤的价值[J].国际放射医学核医学杂志,2002,26(1):4.
CHUAN Ling.Dual-head coincidence technique and the efficiency of detecting tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(6):4.
[2]刘方颖,王全师.18F-FDG PET显像在肺癌中的应用[J].国际放射医学核医学杂志,2002,26(3):114.
LIU Fang-ying,WANG Quan-shi.Application of 18F-FDG PET in lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(6):114.
[3]左传涛.肺癌放射免疫显像的临床应用[J].国际放射医学核医学杂志,2000,24(4):158.
ZUO Chuan-tao.Clinical application of radioimmunoimaging in lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2000,24(6):158.
[4]黄钢,林祥通,赵惠扬.正电子发射计算机断层显像在肺癌中的应用[J].国际放射医学核医学杂志,1998,22(1):11.
[5]楼铁柱,吴德昌.肺癌发生的相关基因研究[J].国际放射医学核医学杂志,1998,22(2):84.
[6]EthelS. Gilbert.氡暴露的健康效应[J].国际放射医学核医学杂志,1999,23(4):174.
[7]张守志,王燮华.室内氡与肺癌关系流行病学研究进展[J].国际放射医学核医学杂志,1999,23(4):177.
[8]杨梅英,叶常青,吴德昌.辐射致肺癌的分子机制[J].国际放射医学核医学杂志,1996,20(2):85.
[9]刘明,单越芬,赵惠扬.一种新的肿瘤标志物:Cyfra 21-1[J].国际放射医学核医学杂志,1995,19(2):69.
[10]张景源.马亚克工厂早期生产人员的放射流行病学[J].国际放射医学核医学杂志,1997,21(5):207.